Supriya Lifescience Limited
Supriya Lifescience Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SUPRIYA and BSE: 543434 (ISIN INE07RO01027).
It has a market capitalisation of ₹7,028 crore, a last close of ₹873.25 on 2026-10-19, a one-year return of 18.2%.
Valuation: a price-to-earnings ratio of 35.43x, a price-to-book ratio of 5.87x, a dividend yield of 0.1%.
Profitability: return on equity of 19.1%, return on capital employed of 24.4%, an operating margin of 33.2%.
Growth: sales growth of 21.6% a year over three years, net profit growth of 32.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 68.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 7,028 |
| Last close | ₹873.25 |
| P/E (TTM) | 35.43x |
| P/B | 5.87x |
| Dividend yield | 0.1% |
| ROE (FY) | 19.1% |
| ROCE (FY) | 24.4% |
| Operating margin (TTM) | 33.2% |
| Sales growth, 3-year CAGR | 21.6% |
| Profit growth, 3-year CAGR | 32.5% |
| Debt / equity | 0.00x |
| Promoter holding | 68.3% |
| 1-year return | 18.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means